For patients who haven't
found lasting relief —
more options exist than you may know.

The honest answer is: it depends on the condition and the protocol. Some applications have substantial clinical evidence — orthopedic cartilage repair, for example, has well-documented outcomes. For neurological conditions, the evidence is more emerging — showing promising signals in research settings and patient-reported improvement, but not yet universally confirmed in large randomized trials. That's why we emphasize case-by-case evaluation rather than blanket claims. We don't promise outcomes — we help you understand what's available and whether it's medically appropriate for your case.

The US FDA tightly regulates stem cell therapies, and many programs available internationally have not yet received FDA approval for specific indications. This doesn't mean they're unsafe — it reflects different regulatory environments and timelines. Countries like Japan, South Korea, Cyprus, and Turkey operate under their own regulatory frameworks that permit certain regenerative programs to be offered in structured clinical settings. Patients travel abroad to access programs that aren't yet available — or are prohibitively expensive — in their home country.

MyMediTour only works with clinics that have been vetted for safety standards, physician qualifications, clinical protocols, and patient transparency. Our partner hospitals include JCI-accredited facilities and specialized centers with demonstrated track records in international patient care. We do not work with unverified clinics or providers who cannot document their processes and medical team credentials. If a clinic can't answer basic questions about their protocols, we don't refer patients to them.

That's a real possibility, and we'll tell you honestly. Not every condition, and not every patient, qualifies for stem cell programs. Factors like age, disease progression, current medications, prior surgeries, and overall health all influence eligibility. If the specialist team determines you're not a candidate, we will let you know clearly — and may be able to suggest alternative options through MyMediTour's other coordination services.

Program durations vary by condition and clinic. Most stem cell programs for neurological or chronic conditions range from 7 to 21 days — some are concentrated over one or two weeks, while more intensive programs for complex neurological conditions may include rehabilitation phases that extend the stay. Your coordinator will walk you through the recommended timeline for your specific case after the initial evaluation.

No. MyMediTour is a medical tourism facilitator — we coordinate, guide, and support. All procedures are performed by licensed physicians at our partner facilities. All medical decisions are made by the treating team, not by MyMediTour. Our role is to help you understand what's available, connect you with the right specialists, handle logistics, and make sure you're informed at every step. We never override medical decisions made by your providers.